Invited Commentaries
Conundrum of Growth and Childhood HIV Infection
Caroline J. Chantry,
Lindsey A. Loomba-Albrecht,
Corresponding Author
Caroline J. Chantry
Department of Pediatrics, University of California Davis Medical Center
Address correspondence and reprint requests to Caroline J. Chantry, MD, Department of Pediatrics, 2516 Stockton Blvd, Suite 334, Sacramento, CA 95817-2208 (e-mail: [email protected]).Search for more papers by this authorLindsey A. Loomba-Albrecht
Department of Pediatrics, University of California Davis Medical Center
Search for more papers by this authorCaroline J. Chantry,
Lindsey A. Loomba-Albrecht,
Corresponding Author
Caroline J. Chantry
Department of Pediatrics, University of California Davis Medical Center
Address correspondence and reprint requests to Caroline J. Chantry, MD, Department of Pediatrics, 2516 Stockton Blvd, Suite 334, Sacramento, CA 95817-2208 (e-mail: [email protected]).Search for more papers by this authorLindsey A. Loomba-Albrecht
Department of Pediatrics, University of California Davis Medical Center
Search for more papers by this authorFirst published: 01 October 2014
The authors report no conflicts of interest.
REFERENCES
- 1 National Center for HIV/AIDS, Viral Hepatitis, STI and TB Prevention. Division of HIV/AIDS Prevention. Center for Disease Control and Prevention. HIV among pregnant women, infants and children in the United States. http://www.cdc.gov/hiv/pdf/risk_WIC.pdf. Published December 2012. Accessed May 17, 2014.
- 2 Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report. UNAIDS report on the global AIDS epidemic. http:/www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf. Published 2013. Accessed May 17, 2014.
- 3Aldrovandi GM, Lindsey JC, Jacobson DL, et al. Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. AIDS 2009; 23: 661–672.
- 4Nachman SA, Lindsey JC, Moye J, et al. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J 2005; 24: 352–357.
- 5Arbeitman LE, O'Brien RC, Somarriba G, et al. Body mass index and waist circumference of HIV-infected youth in a Miami cohort: comparison to local and national cohorts. J Pediatr Gastroenterol Nutr 2014; 59: 449–454.
- 6Williams PL, Abzug MJ, Jacobson DL, et al. Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment. AIDS 2013; 27: 1959–1970.
- 7Shiau S, Arpadi S, Strehlau R, et al. Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus. J Pediatr 2013; 162: 1138–1145.
- 8Villalpando S, Rangel-Baltazar E. Waist-to-height ratio as a predictor of blood pressure in Mexican children. Follow-up study. Rev Invest Clin 2014; 66: 17–23.
- 9Sabah KM, Chowdhury AW, Khan HI, et al. Body mass index and waist/height ratio for prediction of severity of coronary artery disease. BMC Res Notes 2014; 7: 246.
- 10Rondanelli M, Caselli D, Arico M, et al. Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 response to growth hormone is impaired in HIV-infected children. AIDS Res Hum Retroviruses 2002; 18: 331–339.
- 11Van Rossum AM, Gaakeer MI, Verweel S, et al. Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors. Pediatr Infect Dis J 2003; 22: 70–76.
- 12Stanley TL, Grinspoon SK. GH/GHRH axis in HIV lipodystrophy. Pituitary 2009; 12: 143–152.
